A 65-year-old man with a 21% 10-year ASCVD risk should receive which type of statin therapy?

Prepare for the ACCSAP CCKE Coronary Artery Disease Test. Use flashcards and multiple choice questions, complete with hints and explanations. Ensure success on your test!

Multiple Choice

A 65-year-old man with a 21% 10-year ASCVD risk should receive which type of statin therapy?

Explanation:
In primary prevention, when a patient’s 10-year ASCVD risk is 20% or higher, high-intensity statin therapy is recommended because it achieves the largest reduction in LDL and the greatest drop in ASCVD events. A 65-year-old with a 21% risk falls into this high-risk category, so the goal is substantial LDL lowering (about 50% or more). Moderate-intensity statin would reduce risk but not as much, and low-intensity or no statin would miss the opportunity for the best preventive benefit. High-intensity options include atorvastatin 40–80 mg or rosuvastatin 20–40 mg, with ongoing monitoring for tolerance and side effects.

In primary prevention, when a patient’s 10-year ASCVD risk is 20% or higher, high-intensity statin therapy is recommended because it achieves the largest reduction in LDL and the greatest drop in ASCVD events. A 65-year-old with a 21% risk falls into this high-risk category, so the goal is substantial LDL lowering (about 50% or more). Moderate-intensity statin would reduce risk but not as much, and low-intensity or no statin would miss the opportunity for the best preventive benefit. High-intensity options include atorvastatin 40–80 mg or rosuvastatin 20–40 mg, with ongoing monitoring for tolerance and side effects.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy